Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|June 25, 2011
A synthetic optogenetic transcription device enhances blood-glucose homeostasis in miceHaifeng Ye, Marie Daoud-El Baba, Ren-Wang Peng, et al.
Frontiers in Oncology|October 16, 2019
New Horizons in KRAS-Mutant Lung Cancer: Dawn After DarknessHaitang Yang, Shun-Qing Liang, Ralph A Schmid, et al.
Cancers|August 12, 2022
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?Yanyun Gao, Marianna Kruithof-de Julio, Ren-Wang Peng, et al.
Cancers|January 26, 2024
CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer ResearchXian Gong, Jianting Du, Ren-Wang Peng, et al.
Cancers|January 21, 2022
A Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is PunishedWenjuan Ning, Zhang Yang, Gregor J Kocher, et al.
Cancers|November 19, 2020
Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and ImmunityHaitang Yang, Feng Yao, Thomas M Marti, et al.
Discover Oncology|October 3, 2025
The role of LncRNA SNHG3 in human cancersJinming Tang, Min Su, Yuhang Xiao, et al.
Theranostics|January 12, 2023
Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networksKe Xu, Jie Ma, Sean R R Hall, et al.
Cancers|August 23, 2020
Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural MesotheliomaHaitang Yang, Duo Xu, Zhang Yang, et al.
BMC Cancer|February 21, 2016
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMTColin Charles Tièche, Ren-Wang Peng, Patrick Dorn, et al.
Pageof 7